亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

乙胺嘧啶

 
 
單價(jià) 面議對(duì)比
詢價(jià) 暫無
發(fā)貨 湖北武漢市付款后3天內(nèi)
庫(kù)存 9999kg起訂1kg
型號(hào) 58-14-0
過期 長(zhǎng)期有效
更新 2021-07-28 09:12
 

武漢遠(yuǎn)城嘉發(fā)膠原蛋白研究所

企業(yè)會(huì)員第15年
資料未認(rèn)證
保證金未繳納
  • 湖北-武漢市
  • 上次登錄 2021-07-28
  • 陳經(jīng)理 (先生)   經(jīng)理
詳細(xì)說明
乙胺嘧啶 

* 產(chǎn)品名稱:乙胺嘧啶 
* 英文名稱:Pyrimethamine 
* CAS 編號(hào):58-14-0 
* 包裝規(guī)格:25kg 
* 規(guī)格型號(hào):99% 


產(chǎn)品說明: 

乙胺嘧啶 
英文名稱: Pyrimethamine 
CAS號(hào):58-14-0 
分子式:C12H13CLN4
分子量:248.71
性狀:白色結(jié)晶性粉末、無臭、無味。熔  點(diǎn): 239-242℃ ,熾灼殘?jiān)?≤0.1% 
主要用途: 抗瘧藥.用于瘧疾的病因性預(yù)防及抗復(fù)發(fā)治療,醫(yī)藥中間體
質(zhì)量標(biāo)準(zhǔn): 英國(guó)藥典、中國(guó)藥典
包裝:25公斤/桶

關(guān)鍵字:乙胺嘧啶的用途,乙胺嘧啶的性狀,乙胺嘧啶的生產(chǎn)廠家,乙胺嘧啶的價(jià)格  
舉報(bào)收藏 0評(píng)論 0
更多>本企業(yè)其它產(chǎn)品
磷霉素 磷酸氯喹 磷酸泰樂菌素 硫氰酸鈉 氯菊酯 β-環(huán)狀糊精 β-紫羅蘭酮 阿苯達(dá)唑
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |